We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
10:30 - 11:30
A3
Sarcomas
Proffered Papers
Clinical
10:30 - 11:30
Dose reduction in myxoid liposarcoma (DOREMY): long-term update of a multicenter, single-arm, phase II trial
Jules Lansu, The Netherlands
-4909
10:30 - 11:30
Tailoring Radiotherapy Margins in Primary Extremity Soft Tissue Sarcoma: Evidence for Safety and Efficacy from SU2C-SARC032
Siyer Roohani, Canada
-3289
10:30 - 11:30
Prospective phase 2 trial of preoperative intensity modulated proton radiotherapy with simultaneously integrated boost for retroperitoneal sarcomas
Kevin Liu, USA
-2564
10:30 - 11:30
Results of a prospective, single-institution, phase II trial of hypofractionated radiation therapy for inoperable soft tissue sarcoma
Bradley Eckelmann, USA
-5182
10:30 - 11:30
A Phase Ib/II Trial of Radiotherapy Combined with Doxorubicin and Sintilimab for Localized High-Risk Limbs and Trunk Soft Tissue Sarcomas
Zhen Zhang, China
-90
10:30 - 11:30
Multiparametric quantitative MRI: Prospective characterization of soft tissue sarcomas and prediction of radiotherapy response
Benoît Allignet, France
-577